On December 19, 2019, Transtek and Jingdong Health's contract signing ceremony was held at Jingdong headquarter in Beijing. At the same time, the Transtek new product LIFESENSE medical-grade ECG smart health watch H1 was launched at the scene.
The watch with ECG monitoring function has passed Class II medical device certification. It is designed to help end-users obtain medical-grade ECG at any time so that more people can enjoy convenient medical services.
At the signing ceremony, Transtek's chairman David Pan explained the critical position and strategic layout of the LIFESENSE medical-grade ECG watch H1 in the chronic heart disease management system and expressed his expectations JD.com as a domestic launch platform. "JD Health's products and services have initially achieved coverage of the entire pharmaceutical industry chain, pathological processes, health scenarios, and user life cycles. Transtek is looking forward to work with JD Health to perfect "Internet + medical health" ecology, said Mr Pan.
"To cooperate with the company's strategic cooperation with JD.com, Transtek has developed a watch especially for JD Health and COFCO's "sugar control health management service" ABC blood glucose to monitor heart rate and other health data. We believe that smart wearable devices have great potential in the medical field." introduced by Mr. Zhang Guanqun, chief scientist of Transtek.
Transtek has been committed to providing smart and holistic solutions for healthy IoT and big data to customers in areas such as sports health and chronic disease management, with primary medical equipment production and R & D capabilities. "Transtek Cloud" launched a series of mobile Internet products such as "Transtek Health", "Doctor Transtek" and "Transtek ECG" to The watch with ECG monitoring function has passed Class II medical device certification, and it is designed to help end-users obtain medical-grade ECG at any time so that more people can enjoy convenient medical services.
At the signing ceremony, Transtek's chairman David Pan explained the critical position and strategic layout of the LIFESENSE medical-grade ECG watch H1 in the chronic heart disease management system and expressed his expectations JD.com as a domestic launch platform. "JD Health's products and services have initially achieved coverage of the entire pharmaceutical industry chain, pathological processes, health scenarios, and user life cycles. Transtek is looking forward to work with JD Health to perfect "Internet + medical health" ecology, said Mr Pan.
"To cooperate with the company's strategic cooperation with JD.com, Transtek has developed a watch especially for JD Health and COFCO's "sugar control health management service" ABC blood glucose to monitor heart rate and other health data. We believe that smart wearable devices have great potential in the medical field." introduced by Mr. Zhang Guanqun, chief scientist of Transtek.
Transtek has been committed to providing smart and holistic solutions for healthy IoT and big data to customers in sports health and chronic disease management, with primary medical equipment production and R & D capabilities. "Transtek Cloud" launched a series of mobile Internet products such as "Transtek Health", "Doctor Transtek", and "Transtek ECG" The ECG watch H1 aims at providing solutions to continuously prevent cardiovascular disease and solve the pain points of traditional medical methods. It is an essential part of the comprehensive Transtek Health solution. It is Transtek's breakthrough and innovation in smartwatch technology that people can get the medical ECG in 1 minute on Transtek's APP.
Besides, Transtek also provides intelligent data analysis and interpretation services. At present, Transtek has reached cooperation with third-party organizations such as the ECG Department of the Second Affiliated Hospital of Zhengzhou University. Moreover, a large number of professional doctors have joined the online ECG consultation link. It is a complete closed-loop from monitoring analysis to services, providing convenient and efficient medical services. The professional technology and high-quality service of LIFESENSE medical-grade ECG watches have proved to the public the outstanding quality of Transtek and the applicability of smart wearable devices in the professional medical field will bring health gospel to the majority of patients.
Mr Xu Yangshun, Chief Operating Officer of Transtek Medical, stated that Transtek hopes to use this product to strengthen heart health management, fill the gap in medical resources, and let more users enjoy a good health time. In the future, Transtek will always adhere to the concept of "healthy body, happy life, and be at ease for your family", and create a new generation of a smart and healthy lifestyle for end users.
LIFESENSE medical-grade ECG watches H1 will be available on January 1, 2020.
